| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
|
Cancer
|
2009
|
3.12
|
|
2
|
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
|
Eur Urol
|
2009
|
2.55
|
|
3
|
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
|
Eur Urol
|
2011
|
2.43
|
|
4
|
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
|
Eur Urol
|
2012
|
2.13
|
|
5
|
Identification of the retrotrigonal layer as a key anatomical landmark during robotically assisted radical prostatectomy.
|
BJU Int
|
2006
|
2.10
|
|
6
|
Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue.
|
Eur Urol
|
2008
|
2.03
|
|
7
|
Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty.
|
Urology
|
2009
|
1.96
|
|
8
|
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
|
Eur Urol
|
2009
|
1.92
|
|
9
|
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
|
J Urol
|
2009
|
1.90
|
|
10
|
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
|
BJU Int
|
2011
|
1.78
|
|
11
|
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
|
Eur Urol
|
2009
|
1.78
|
|
12
|
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
|
Eur Urol
|
2012
|
1.65
|
|
13
|
Laparoendoscopic single-site surgery in urology: where have we been and where are we heading?
|
Nat Clin Pract Urol
|
2008
|
1.62
|
|
14
|
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
|
Cancer
|
2010
|
1.58
|
|
15
|
Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?
|
BJU Int
|
2013
|
1.57
|
|
16
|
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
|
Eur Urol
|
2012
|
1.57
|
|
17
|
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.
|
J Clin Oncol
|
2008
|
1.54
|
|
18
|
Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity.
|
Urology
|
2010
|
1.54
|
|
19
|
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
|
J Endourol
|
2011
|
1.53
|
|
20
|
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
|
J Urol
|
2009
|
1.52
|
|
21
|
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.
|
BJU Int
|
2013
|
1.52
|
|
22
|
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
|
BJU Int
|
2011
|
1.50
|
|
23
|
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
|
BJU Int
|
2007
|
1.50
|
|
24
|
Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
|
BJU Int
|
2012
|
1.48
|
|
25
|
An obese body habitus does not preclude a minimally invasive partial nephrectomy.
|
Can J Urol
|
2014
|
1.48
|
|
26
|
Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
|
BJU Int
|
2014
|
1.45
|
|
27
|
Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
|
Urology
|
2013
|
1.44
|
|
28
|
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
|
J Urol
|
2010
|
1.44
|
|
29
|
Impact of warm versus cold ischemia on renal function following partial nephrectomy.
|
World J Urol
|
2014
|
1.43
|
|
30
|
Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center.
|
Urology
|
2011
|
1.41
|
|
31
|
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
|
J Urol
|
2010
|
1.40
|
|
32
|
Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
|
Eur Urol
|
2010
|
1.26
|
|
33
|
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
|
Eur Urol
|
2012
|
1.21
|
|
34
|
How physician and patient perceptions differ regarding medical management of stone disease.
|
J Urol
|
2009
|
1.17
|
|
35
|
Synchronous bilateral percutaneous nephrostolithotomy: analysis of clinical outcomes, cost and surgeon reimbursement.
|
J Urol
|
2008
|
1.13
|
|
36
|
Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy.
|
JSLS
|
2008
|
1.11
|
|
37
|
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
|
Eur Urol
|
2012
|
1.10
|
|
38
|
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
|
Urology
|
2006
|
1.05
|
|
39
|
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.
|
BJU Int
|
2009
|
1.05
|
|
40
|
Chronic kidney disease before and after partial nephrectomy.
|
J Urol
|
2010
|
1.05
|
|
41
|
Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?
|
Urol Oncol
|
2008
|
1.04
|
|
42
|
Residual fragments following ureteroscopic lithotripsy: incidence and predictors on postoperative computerized tomography.
|
J Urol
|
2012
|
1.03
|
|
43
|
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
|
BJU Int
|
2008
|
1.03
|
|
44
|
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
|
BJU Int
|
2013
|
1.00
|
|
45
|
Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy.
|
Urology
|
2008
|
1.00
|
|
46
|
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
|
BJU Int
|
2008
|
0.99
|
|
47
|
Laparoscopic adrenalectomy for large adrenal masses.
|
Curr Urol Rep
|
2008
|
0.98
|
|
48
|
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
|
J Urol
|
2012
|
0.96
|
|
49
|
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
|
J Urol
|
2012
|
0.95
|
|
50
|
Determinants of quality of life for patients with kidney stones.
|
J Urol
|
2008
|
0.95
|
|
51
|
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
|
Urology
|
2008
|
0.92
|
|
52
|
Complications during the initial experience with laparoendoscopic single-site pyeloplasty.
|
BJU Int
|
2011
|
0.92
|
|
53
|
High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection.
|
J Endourol
|
2012
|
0.91
|
|
54
|
Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma.
|
J Manag Care Pharm
|
2011
|
0.90
|
|
55
|
Current status of renal radiofrequency ablation.
|
Curr Opin Urol
|
2009
|
0.90
|
|
56
|
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
|
J Urol
|
2012
|
0.90
|
|
57
|
Predictive factors of recurrence and survival of upper tract urothelial carcinomas.
|
World J Urol
|
2011
|
0.88
|
|
58
|
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
|
World J Urol
|
2012
|
0.88
|
|
59
|
Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate.
|
World J Urol
|
2014
|
0.87
|
|
60
|
Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis.
|
Urology
|
2006
|
0.87
|
|
61
|
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
|
Urol Oncol
|
2011
|
0.86
|
|
62
|
Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.
|
J Urol
|
2010
|
0.86
|
|
63
|
General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
|
J Endourol
|
2009
|
0.86
|
|
64
|
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
|
BJU Int
|
2011
|
0.86
|
|
65
|
A delay in radical nephroureterectomy can lead to upstaging.
|
BJU Int
|
2009
|
0.85
|
|
66
|
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.
|
BJU Int
|
2009
|
0.85
|
|
67
|
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.
|
J Urol
|
2011
|
0.85
|
|
68
|
Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.
|
Cancer
|
2014
|
0.84
|
|
69
|
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
|
Urol Oncol
|
2010
|
0.84
|
|
70
|
Management and prevention of renal ablative therapy complications.
|
World J Urol
|
2010
|
0.84
|
|
71
|
The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
|
Can J Urol
|
2012
|
0.83
|
|
72
|
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
|
Urology
|
2005
|
0.83
|
|
73
|
Predictors of cost and clinical outcomes of percutaneous nephrostolithotomy.
|
J Urol
|
2009
|
0.83
|
|
74
|
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
|
J Urol
|
2012
|
0.82
|
|
75
|
Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma.
|
Expert Rev Anticancer Ther
|
2014
|
0.82
|
|
76
|
Ergonomics considerations of radical prostatectomy: physician perspective of open, laparoscopic, and robot-assisted techniques.
|
J Endourol
|
2009
|
0.82
|
|
77
|
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
|
BJU Int
|
2013
|
0.82
|
|
78
|
Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
|
BJU Int
|
2009
|
0.81
|
|
79
|
Bladder cancer following upper tract urothelial carcinoma.
|
Expert Rev Anticancer Ther
|
2008
|
0.81
|
|
80
|
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
|
World J Urol
|
2011
|
0.81
|
|
81
|
Retroperitoneal lymph node dissection after chemotherapy.
|
BJU Int
|
2009
|
0.81
|
|
82
|
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.
|
Biomark Med
|
2008
|
0.79
|
|
83
|
Optical reflectance spectroscopy to differentiate benign from malignant renal tumors at surgery.
|
Urology
|
2008
|
0.79
|
|
84
|
Laparoendoscopic single-site pyeloplasty.
|
Ther Adv Urol
|
2011
|
0.79
|
|
85
|
Surgery: is perinephric drainage essential after partial nephrectomy?
|
Nat Rev Urol
|
2011
|
0.79
|
|
86
|
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.
|
Ann Surg Oncol
|
2012
|
0.78
|
|
87
|
Current status of ablative techniques for small renal masses.
|
Expert Rev Anticancer Ther
|
2011
|
0.78
|
|
88
|
Renal tumor ablation is a function of patient selection and technique--not the ablation technology.
|
Cancer
|
2008
|
0.78
|
|
89
|
Does obesity impact the costs of partial and radical nephrectomy?
|
J Urol
|
2008
|
0.78
|
|
90
|
Predictors of survival in patients with disease recurrence after radical nephroureterectomy.
|
BJU Int
|
2014
|
0.78
|
|
91
|
Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
|
Int Braz J Urol
|
2013
|
0.78
|
|
92
|
Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma.
|
Can J Urol
|
2014
|
0.77
|
|
93
|
Cutaneous renocolic fistula associated with diverticulitis.
|
Can J Urol
|
2008
|
0.77
|
|
94
|
Re: Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review D. A. Kunkle, B. L. Egleston and R. G. Uzzo J Urol 2008; 179: 1227-1234.
|
J Urol
|
2008
|
0.76
|
|
95
|
The role of lymphadenectomy for upper tract urothelial carcinoma.
|
Nat Rev Urol
|
2011
|
0.76
|
|
96
|
Conservative nephron-sparing treatment of upper-tract tumors.
|
Curr Urol Rep
|
2013
|
0.76
|
|
97
|
Editorial Comment from Dr Kaag and Dr Raman to Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy.
|
Int J Urol
|
2014
|
0.75
|
|
98
|
Editorial comment.
|
Urology
|
2010
|
0.75
|
|
99
|
Editorial Comment to renal pelvic villous adenoma presented with mucusuria: report of a case and literature review.
|
Int J Urol
|
2012
|
0.75
|
|
100
|
Re: Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. E. Comperat, M. Roupret, E. Chartier-Kastler, M. O. Bitker, F. Richard, P. Camparo, F. Capron and O. Cussenot. J Urol 2008; 179: 868-872.
|
J Urol
|
2008
|
0.75
|
|
101
|
Small renal masses: is LESS partial nephrectomy feasible for most urologists?
|
Nat Rev Urol
|
2013
|
0.75
|
|
102
|
Editorial comment.
|
J Urol
|
2011
|
0.75
|
|
103
|
Re: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. S. Baltaci, E. Suer, A. H. Haliloglu, M. I. Gokce, A. H. Elhan and Y. Beduk. J Urol 2009; 181: 128-132.
|
J Urol
|
2009
|
0.75
|
|
104
|
Re: Single port transumbilical (E-NOTES) donor nephrectomy: I. S. Gill, D. Canes, M. Aron, G.-P. Haber, D. A. Goldfarb, S. Flechner, M. R. Desai, J. H. Kaouk and M. M. Desai J Urol 2008; 180: 637-641.
|
J Urol
|
2008
|
0.75
|
|
105
|
Editorial comment.
|
Urology
|
2009
|
0.75
|
|
106
|
Infectious complications following prostate biopsy: a problem with need for solution.
|
Can J Urol
|
2013
|
0.75
|
|
107
|
Editorial comment. The natural history of renal stone fragments following ureteroscopy.
|
Urology
|
2011
|
0.75
|
|
108
|
Laparoscopic radical nephrectomy for renal masses 7 centimeters or larger.
|
JSLS
|
2009
|
0.75
|
|
109
|
Systemic chemotherapy and radical nephroureterectomy.
|
Int Urol Nephrol
|
2015
|
0.75
|
|
110
|
Needlescopic ablation of small adrenal masses.
|
Curr Urol Rep
|
2009
|
0.75
|
|
111
|
Exploration of treatment options for the management of stage I testicular seminoma.
|
Expert Rev Anticancer Ther
|
2008
|
0.75
|
|
112
|
Prognostic markers and targeted therapies for renal cell carcinoma.
|
Future Oncol
|
2009
|
0.75
|
|
113
|
Has laparoscopy impacted the indications for adrenalectomy?
|
Curr Urol Rep
|
2010
|
0.75
|
|
114
|
Robotic assisted laparoscopic repair of a symptomatic ureterosciatic hernia.
|
Can J Urol
|
2016
|
0.75
|
|
115
|
Contemporary management of small renal masses: does practice environment matter?
|
Can J Urol
|
2012
|
0.75
|
|
116
|
A comparison of kidney oxygenation profiles between partial and complete renal artery clamping during nephron sparing surgery in a porcine model.
|
Can J Urol
|
2009
|
0.75
|
|
117
|
Are urology residents adequately exposed to conservative therapies for managing small renal masses?
|
J Endourol
|
2011
|
0.75
|
|
118
|
Procedural povidone iodine rectal preparation reduces bacteriuria and bacteremia following prostate needle biopsy.
|
Can J Urol
|
2017
|
0.75
|